Market Research Logo

Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review

Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides services such as integrated services, assay development and screening, reagent production services, ADMET, cellular target profiling, vitro pharmacology services and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and also has development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Manchester, the UK; Gottingen and Munich, Germany; South San Francisco, Branford and Princeton, the US; and Toulouse, France. Evotec is headquartered in Hamburg, Germany.

Evotec AG Key Recent Developments

Jul 04,2018: Sanofi integrates infectious disease unit into Evotec
Jun 25,2018: Evotec Achieves Second Milestone in Diabetes Alliance With Sanofi
May 31,2018: Arix Bioscience Forms Strategic Collaboration with Evotec AG and Fred Hutchinson Cancer Research Center to Foster New Companies in Cancer and Infectious Diseases
May 31,2018: Evotec forms academic BRIDGE 'LAB591’ with Arix Bioscience and Fred Hutchinson Cancer Research Center
May 09,2018: Evotec Reports First Quarter 2018 Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Evotec AG - Key Facts
Evotec AG - Key Employees
Evotec AG - Key Employee Biographies
Evotec AG - Major Products and Services
Evotec AG - History
Evotec AG - Company Statement
Evotec AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Evotec AG - Business Description
Business Segment: EVT Execute Segment
Overview
Performance
Business Segment: EVT Innovate Segment
Overview
Performance
R&D Overview
Evotec AG - SWOT Analysis
SWOT Analysis - Overview
Evotec AG - Strengths
Evotec AG - Weaknesses
Evotec AG - Opportunities
Evotec AG - Threats
Evotec AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Evotec AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Evotec AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 04, 2018: Sanofi integrates infectious disease unit into Evotec
Jun 25, 2018: Evotec Achieves Second Milestone in Diabetes Alliance With Sanofi
May 31, 2018: Arix Bioscience Forms Strategic Collaboration with Evotec AG and Fred Hutchinson Cancer Research Center to Foster New Companies in Cancer and Infectious Diseases
May 31, 2018: Evotec forms academic BRIDGE 'LAB591’ with Arix Bioscience and Fred Hutchinson Cancer Research Center
May 09, 2018: Evotec Reports First Quarter 2018 Results and Provides Corporate Update
May 02, 2018: Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
Mar 27, 2018: Evotec plans conversion into European Company (SE)
Mar 26, 2018: Evotec Launches INDIGO, A Unique Integrated Drug Development Solution for Accelerating Early Drug Candidates into the Clinic
Feb 28, 2018: Novo Holdings announce Launch of REPAIR and formation of scientific selection board
Jan 08, 2018: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Evotec AG, Key Facts
Evotec AG, Key Employees
Evotec AG, Key Employee Biographies
Evotec AG, Major Products and Services
Evotec AG, History
Evotec AG, Subsidiaries
Evotec AG, Joint Venture
Evotec AG, Key Competitors
Evotec AG, Ratios based on current share price
Evotec AG, Annual Ratios
Evotec AG, Annual Ratios (Cont...1)
Evotec AG, Annual Ratios (Cont...2)
Evotec AG, Interim Ratios
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Evotec AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Evotec AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Evotec AG, Performance Chart (2013 - 2017)
Evotec AG, Ratio Charts
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Evotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report